Anaptysbio Stock Technical Analysis
| ANAB Stock | USD 53.09 0.01 0.02% |
As of the 16th of February 2026, AnaptysBio shows the risk adjusted performance of 0.1801, and Mean Deviation of 2.52. AnaptysBio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
AnaptysBio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as AnaptysBio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AnaptysBioAnaptysBio | Build AI portfolio with AnaptysBio Stock |
AnaptysBio Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 67.92 | Strong Buy | 12 | Odds |
Most AnaptysBio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AnaptysBio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AnaptysBio, talking to its executives and customers, or listening to AnaptysBio conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive AnaptysBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.82) | Revenue Per Share | Quarterly Revenue Growth 1.543 | Return On Assets | Return On Equity |
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that AnaptysBio's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AnaptysBio represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, AnaptysBio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
AnaptysBio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AnaptysBio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AnaptysBio.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in AnaptysBio on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding AnaptysBio or generate 0.0% return on investment in AnaptysBio over 90 days. AnaptysBio is related to or competes with Xencor, Oculis Holding, Phathom Pharmaceuticals, UroGen Pharma, Nurix Therapeutics, BridgeBio Oncology, and Kodiak Sciences. AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for infla... More
AnaptysBio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AnaptysBio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AnaptysBio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.19 | |||
| Information Ratio | 0.1934 | |||
| Maximum Drawdown | 17.62 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.6 |
AnaptysBio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AnaptysBio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AnaptysBio's standard deviation. In reality, there are many statistical measures that can use AnaptysBio historical prices to predict the future AnaptysBio's volatility.| Risk Adjusted Performance | 0.1801 | |||
| Jensen Alpha | 0.7273 | |||
| Total Risk Alpha | 0.4701 | |||
| Sortino Ratio | 0.2087 | |||
| Treynor Ratio | (29.63) |
AnaptysBio February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1801 | |||
| Market Risk Adjusted Performance | (29.62) | |||
| Mean Deviation | 2.52 | |||
| Semi Deviation | 2.6 | |||
| Downside Deviation | 3.19 | |||
| Coefficient Of Variation | 467.83 | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.85 | |||
| Information Ratio | 0.1934 | |||
| Jensen Alpha | 0.7273 | |||
| Total Risk Alpha | 0.4701 | |||
| Sortino Ratio | 0.2087 | |||
| Treynor Ratio | (29.63) | |||
| Maximum Drawdown | 17.62 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.6 | |||
| Downside Variance | 10.18 | |||
| Semi Variance | 6.77 | |||
| Expected Short fall | (2.87) | |||
| Skewness | 0.2162 | |||
| Kurtosis | 0.9749 |
AnaptysBio Backtested Returns
AnaptysBio appears to be very steady, given 3 months investment horizon. AnaptysBio secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19 % return per unit of standard deviation over the last 3 months. By analyzing AnaptysBio's technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please makes use of AnaptysBio's mean deviation of 2.52, and Risk Adjusted Performance of 0.1801 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AnaptysBio holds a performance score of 14. The firm shows a Beta (market volatility) of -0.0245, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AnaptysBio are expected to decrease at a much lower rate. During the bear market, AnaptysBio is likely to outperform the market. Please check AnaptysBio's mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to make a quick decision on whether AnaptysBio's price patterns will revert.
Auto-correlation | 0.72 |
Good predictability
AnaptysBio has good predictability. Overlapping area represents the amount of predictability between AnaptysBio time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AnaptysBio price movement. The serial correlation of 0.72 indicates that around 72.0% of current AnaptysBio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 9.3 |
AnaptysBio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
AnaptysBio Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for AnaptysBio across different markets.
About AnaptysBio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AnaptysBio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AnaptysBio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AnaptysBio price pattern first instead of the macroeconomic environment surrounding AnaptysBio. By analyzing AnaptysBio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AnaptysBio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AnaptysBio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 145.75 | 163.01 | 146.71 | 154.04 | PTB Ratio | 6.55 | 5.3 | 6.1 | 5.79 |
AnaptysBio February 16, 2026 Technical Indicators
Most technical analysis of AnaptysBio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AnaptysBio from various momentum indicators to cycle indicators. When you analyze AnaptysBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1801 | |||
| Market Risk Adjusted Performance | (29.62) | |||
| Mean Deviation | 2.52 | |||
| Semi Deviation | 2.6 | |||
| Downside Deviation | 3.19 | |||
| Coefficient Of Variation | 467.83 | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.85 | |||
| Information Ratio | 0.1934 | |||
| Jensen Alpha | 0.7273 | |||
| Total Risk Alpha | 0.4701 | |||
| Sortino Ratio | 0.2087 | |||
| Treynor Ratio | (29.63) | |||
| Maximum Drawdown | 17.62 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.6 | |||
| Downside Variance | 10.18 | |||
| Semi Variance | 6.77 | |||
| Expected Short fall | (2.87) | |||
| Skewness | 0.2162 | |||
| Kurtosis | 0.9749 |
AnaptysBio February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as AnaptysBio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.09 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 55.11 | ||
| Day Typical Price | 54.43 | ||
| Price Action Indicator | (2.01) | ||
| Market Facilitation Index | 5.09 |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |